We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Principal Investment Grade Corporate Active ETF | AMEX:IG | AMEX | Exchange Traded Fund |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.12 | 0.60% | 20.28 | 20.28 | 20.2034 | 20.28 | 20,605 | 21:00:10 |
From May 2019 to May 2024
BUENA, N.J., Oct. 14, 2016 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30 pm ET on Thursday, October 27, 2016 to discuss the 3rd quarter 2016 results.
The Company invites you to listen to the call by dialing 1-888-346-3479. International participants should call 1-412-902-4260. Canadian participants should call 1-855-669-9657. Participants should ask to be joined into the Teligent, Inc. call.
This call is being webcast by MultiVu (a PR Newswire Company) and can be accessed in the Investor Relations Section of Teligent Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
|
Contact: |
Jenniffer Collins |
|
Teligent, Inc. | |
|
(856) 697-4379 | |
|
www.teligent.com |
Logo - http://photos.prnewswire.com/prnh/20151022/279641LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-hold-conference-call-for-3rd-quarter-2016-results-300344900.html
SOURCE Teligent, Inc.
Copyright 2016 PR Newswire
1 Year Principal Investment Gra... Chart |
1 Month Principal Investment Gra... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
